Rekah Pharmaceutical Industry

Rekah Pharmaceutical Industry is a leading Israeli pharmaceutical group specializing in the development, manufacture, and distribution of generic medications and healthcare products. The company maintains a comprehensive portfolio that includes prescription drugs, over-the-counter (OTC) medicines, vitamins, and medical supplies across diverse therapeutic categories such as dermatology, respiratory, and pain management. Rekah operates through several key subsidiaries, including Vitamed and Ophir, and possesses advanced manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards. In addition to its own product lines, the company serves as a significant distributor for international pharmaceutical brands within the Israeli market. Rekah is publicly traded on the Tel Aviv Stock Exchange and is partially owned by the FIMI Opportunity Funds.